Search Results
2019-2021 D.F. Torgerson Award: Actinium-225 Production Team
Critical evaluation of Quality Control procedures for actinium 225 radiopharmaceuticals
Actinium-225 |Q & A session with the Experts | Dr. N. Ramamoorthy, Sr. Advisor to Director, BARC
Actinium Pharmaceuticals Webcast Presentation @ Lytham Partners Spring 2022 Investor Conference
Future of Nuclear Medicine in Treatment of NETs (Actinium 225) - Dr. Philip Cohen (Nuclear Medicine)
2019-2021 CNL Awards of Excellence: Crowdfunding Initiative
Actinium-225 A Cancer Fighting Medical Isotope, Hopeful in Curing Cancer
Meet Actinium
Actinium Pharmaceuticals, Inc.– Leading the next revolution in targeted radiotherapy.
Bill Gates' Treatment For Cancer a Potential Lifesaver
Digital Visualization at Canadian Nuclear Laboratories
Medical Actinium Therapeutic Treatment
